Company Overview

Company name: Tikun Olam
Description: Operator of medical cannabis research and development in Israel. The company breeds proprietary cannabis strains and develops standardized products with accurate dosage their production techniques focus on increasing the efficacy of the active ingredients in the plant to provide clients with clean and chemical free cannabis.
Year founded: 2005
Parent company: Cannbit Pharmaceuticals
Industry: Healthcare | Group: | Code:
Website: www.tikunolam.com
Employees:
City: Tel Aviv-Yafo
State:
Country: Israel
Region:

Financial Highlights

Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company was acquired by Cannbit Pharmaceuticals (TAE: CANNBIT), a subsidiary of Tamir Fishman, for $41 million on November 25, 2019. The amount also considers $18 million to be paid within five years after the acquisition.
Number of active investors:
Profile last updated: 30-Jan-2020
Last known valuation:
Last known valuation date: 25-Nov-2019